NPPB and hydrops fetalis: By contrast, sacubitril/valsartan consistently lowers NT-proBNP (with BNP behavior influenced by neprilysin inhibition) and, in PARADIGM-HF, did not raise serum potassium overall, with treatment benefits preserved across the potassium spectrum [19,20].